THE MODE OF ACTION OF A COAGULATION INHIBITOR IN THE BLOOD OF TWO PATIENTS WITH DISSEMINATED LUPUS ERYTHEMATOSUS (DLE).
D001776:Blood Circulation Time; D001778:Blood Coagulation Disorders; D001780:Blood Coagulation Tests; D001921:Brain; D002648:Child; D004844:Epistaxis; D005164:Factor IX; D005169:Factor VIII; D005170:Factor X; D005172:Factor XI; D005340:Fibrinogen; D006417:Hematuria; D006801:Humans; D008180:Lupus Erythematosus, Systemic; D009504:Neutrophils; D011516:Prothrombin; D012106:Research; D014020:Tissue Extracts
D014020:Tissue Extracts; C427184:recombinant factor VIII SQ; D011516:Prothrombin; D005169:Factor VIII; D005164:Factor IX; D005170:Factor X; D005340:Fibrinogen; D005172:Factor XI
BLOOD CIRCULATION TIME; BLOOD COAGULATION DISORDERS; BLOOD COAGULATION TESTS; BRAIN; CHILD; EPISTAXIS; EXPERIMENTAL LAB STUDY; FACTOR IX; FACTOR VIII; FACTOR X; FACTOR XI; FIBRINOGEN; HEMATURIA; LE CELLS; LUPUS ERYTHEMATOSUS, SYSTEMIC; PROTHROMBIN; TISSUE EXTRACTS